With Talk of Legislation Heating Up, PhRMA Seeks a New 340B Policy Director

PhRMA wordmark repeated on a background
PhRMA is seeking a new director for its policy and research team to help develop and lead implementation of work on 340B.

Pharmaceutical Research and Manufacturers of America (PhRMA) is seeking a new director for its policy and research team to help develop and lead implementation of work on 340B and related hospital cost and affordability issues, according to an employment solicitation

Read More »

Maryland Governor Signs 340B Anti-discrimination Bill into Law

Maryland Gov. Larry Hogan (R) signing a document
Maryland Gov. Larry Hogan (R) has signed legislation barring PBM discrimination against 340B covered entities and contract pharmacies.

Maryland Gov. Larry Hogan (R) has signed legislation prohibiting pharmacy benefit manager (PBM) discrimination against 340B covered entities and their contract pharmacies.

Hogan signed HB 1274 into law on May 16. It takes effect Oct. 1. The state House and Senate

Read More »

In What Would Be the Only Second State to Enact Such Legislation, Calif. Senate Votes to Shield 340B Providers from Manufacturers and PBMs’ Actions

California Senate chamber interior
The California Senate passed legislation to bar drug manufacturer conditions on covered entities’ 340B drug purchases and to bar pharmacy benefit manager (PBM) discrimination against 340B covered entities and their pharmacies.

The California Senate passed legislation yesterday to prohibit drug manufacturer conditions on covered entities’ 340B drug purchases and to prohibit pharmacy benefit manager (PBM) discrimination against 340B covered entities and their pharmacies.

The Senate voted 24-9 in favor of SB-939 and

Read More »

State Bill That Would Have Stopped Drug Industry from Imposing 340B Contract Pharmacy Restrictions Dies

Connecticut Senate chamber interior
A 340B anti-discrimination bill targeting pharmacy benefit managers and drug manufacturers failed to advance in Connecticut.

Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on May 4.

Read More »

Colorado Lawmakers Pass 340B Anti-discrimination Bill

Colorado state capitol building
Colorado lawmakers voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

The Colorado General Assembly has voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

Gov. Jared Polis (D) is expected to sign the bill, HB22-1122. He

Read More »

340B Providers Lose their Biggest GOP Ally in U.S. House

U.S. Rep. David McKinley (R-WA) gestures during hearing
U.S. Rep. David McKinley (R-W.Va.) lost his GOP primary election this week. It's a huge blow for 340B entities that have relied on his help in Congress for years.

In a major blow to the 340B provider community, U.S. Rep. David McKinley, the leading voice for the 340B program in the House Republican caucus, was defeated Tuesday in the West Virginia Republican primary. McKinley will remain in office until

Read More »

Drug Makers Ask Michigan Lawmakers to Erase Section from New 340B State Law

Copy of State of Michigan bill no. 4351
Michigan 340B hospitals say drug manufacturers are lobbying state lawmakers to erase language from a new state law that the hospitals say stops the drug makers from imposing claims submission requirements as a condition for 340B pricing.

Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B

Read More »

Sen. Grassley Presses HHS OIG to Punish Drug Makers Over Denials of 340B Pricing

Sen. Chuck Grassley (R-IA) headshot
U.S. Sen. Chuck Grassley (R-Iowa) wants to know if HHS will impose civil monetary penalties on drug companies that deny 340B pricing over multiple contract pharmacy.

Senate Finance Committee ranking Republican Chuck Grassley (Iowa) yesterday asked the U.S. Health and Human Services Department of Inspector General (OIG) if it plans to punish seven drug companies over their denials of 340B pricing when hospitals, health centers, and

Read More »

Sen. Manchin Endorses 340B Ally McKinley in Tight GOP Primary Race

Sen. Joe Manchin (D-WV) and Rep. David McKinley (R-WV) headshots
Conservative Democratic U.S. Sen. Joe Manchin has endorsed moderate Republican Rep. David McKinley in West Virginia's GOP congressional primary election next week against Rep. Alex Mooney, who is backed by ex-President Trump.

Conservative Democratic U.S. Sen. Joe Manchin (W.Va.) has endorsed and appeared in a campaign advertisement for Republican Rep. David McKinley (W.Va.), a moderate being challenged for re-election by a candidate endorsed by ex-President Donald Trump.

The GOP primary between McKinley

Read More »

With Retired Sen. Hatch’s Passing, a Legendary 340B Tale is Told

Sen. Orrin Hatch headshot
Retired U.S. Sen. Orrin Hatch (R-Utah), who died this weekend, played a key role in 340B's creation and development.

Retired U.S. Sen. Orrin Hatch of Utah, a conservative Republican icon who helped create and shape the 340B drug pricing program, has died. He was 88.

Hatch personally was responsible for choosing one of the 340B program’s most important covered

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report